A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Autosomal Dominant Polycystic Kidney Disease (ADPKD)

In brief

The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics of VX-407 in healthy participants.

Key facts

Study ID
NCT07022119
Run by
Vertex Pharmaceuticals Incorporated
People needed
32
Starts
2025-06-12
Expected to finish
2026-02-24
Last updated by the study team
2026-03-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.